坎迪达菌中的抗真菌药物耐药性:特别强调安福特素B
Lailema Ahmady1, Manisha Gothwal1, Muhammed Mushthaque Mukkoli1
1Department of Biochemistry, School of Basic Sciences, Central University of Punjab, Bathinda, India.
概括
来自Candida物种的侵入性真菌感染正在增加,特别是在脆弱的患者中. 本综述侧重于Candida的抗真菌药物耐药性,特别是安二B耐药性机制.
科学领域:
- 医学真菌学 医学真菌学
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 由Candida物种引起的侵入性真菌感染正在增加,特别是在免疫受损和重症患者中,导致显著的发病率和死亡率.
- 导致这一增长的因素包括人口老龄化,免疫抑制药物的使用增加以及免疫性疾病的流行率.
- 虽然Candida albicans是最常见的,但非白虫的Candida物种也是重要的病原体.
研究的目的:
- 审查Candida物种当前抗真菌药物耐药性的情况.
- 专注于对安福特素B (AmB) 的耐药性机制.
- 为了突出治疗入侵性真菌感染的挑战,由于新兴的耐药性.
主要方法:
- 在Candida物种中对抗真菌药物耐药性的文献综述.
- 专注于安福特里辛B (AmB) 作为一种关键的抗真菌剂.
- 对AmB耐药性背后的机制的分析,包括对ergosterol的改变.
主要成果:
- 坎迪达菌种对可用的抗真菌药物表现出耐药性,使治疗复杂化.
- 抗 B 氨基氨酸耐药性主要与真菌的 ergosterol 含量或结构的变化有关.
- 新兴的耐药性需要对药物和真菌相互作用有更深入的了解.
结论:
- 在Candida的抗真菌药物耐药性构成了重大的临床挑战.
- 了解抗药性机制,特别是安二乙的抗药性机制,对于开发有效的治疗策略至关重要.
- 需要继续进行研究,以应对侵袭性真菌感染日益严重的威胁.
相关概念视频
Combined Effects of Drugs: Synergism
6.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.2K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
602
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
602
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
141
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
141
Development of Antibiotic Resistance
2.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Inhibitors of Gram-positive Cell Wall Synthesis
191
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
191


